Figure 2.
Figure 2. Overall survival for patients assigned to rituximab and fludarabine on CALGB 9712 versus fludarabine on CALGB 9011. CALGB 9712 (solid line) and CALGB 9011 (divided line).

Overall survival for patients assigned to rituximab and fludarabine on CALGB 9712 versus fludarabine on CALGB 9011. CALGB 9712 (solid line) and CALGB 9011 (divided line).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal